Compare OCC & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCC | CVRX |
|---|---|---|
| Founded | 1983 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.2M | 139.8M |
| IPO Year | 2001 | 2021 |
| Metric | OCC | CVRX |
|---|---|---|
| Price | $15.95 | $2.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 191.8K | ★ 978.3K |
| Earning Date | 06-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 290.91 | 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $87,828,590.00 | $56,651,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $17.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 37.03 | 10.45 |
| 52 Week Low | $4.02 | $2.20 |
| 52 Week High | $27.98 | $11.30 |
| Indicator | OCC | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.36 | 28.34 |
| Support Level | $12.65 | N/A |
| Resistance Level | $16.72 | $6.08 |
| Average True Range (ATR) | 1.30 | 0.33 |
| MACD | 0.22 | -0.29 |
| Stochastic Oscillator | 68.08 | 9.47 |
Optical Cable Corp manufactures a broad range of fiber optic and copper data communication cabling and connectivity solutions for the enterprise, wireless carrier, and specialty markets. The Company offers high quality products that operate as a system solution or integrate with other components, including fiber, copper, hybrid cabling, cabinets, racks, enclosures, and deployable solutions for enterprise networks, data centers, residential, campus, Passive Optical LAN installations, and customized applications in military, industrial, mining, petrochemical, renewable energy, and broadcast industries. It operates a single reportable segment covering the design, development, manufacture, and marketing of its cabling and connectivity solutions.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.